RT Journal Article
SR Electronic
T1 Discerning divergent tuberculosis endotypes: A meta-analysis and systematic review of individual patient data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.13.20100776
DO 10.1101/2020.05.13.20100776
A1 DiNardo, Andrew R.
A1 Rajapakshe, Kimal
A1 Gandhi, Tanmay
A1 Grimm, Sandra L.
A1 Nishiguchi, Tomoki
A1 Heyckendorf, Jan
A1 Kahari, Jaqueline
A1 Dlamini, Qiniso
A1 Lange, Christoph
A1 Cirillo, Jeffrey D.
A1 Kaufmann, Stefan HE
A1 Crevel, Reinout van
A1 Netea, Mihai G.
A1 Mandalakas, Anna M.
A1 Coarfa, Cristian
YR 2020
UL http://medrxiv.org/content/early/2020/05/16/2020.05.13.20100776.abstract
AB Rationale Host response is a critical factor determining susceptibility to tuberculosis (TB). A delicate balance should be maintained between intracellular immunity against Mycobacterium tuberculosis (Mtb) and minimizing detrimental immunopathology. Studies have identified incongruous immune responses that can lead to a similar TB disease phenotype. Instead of envisioning that susceptibility to TB follows a singular path, we propose the hypothesis that varied host endotypes exist within the TB clinical phenotype.Methods and Results Unbiased clustering analysis from 12 publicly available gene expression datasets consisting of data from 717 TB patients and 527 controls, identified 4 TB patient endotypes with distinct immune responses. The two largest endotypes exhibit divergent metabolic, epigenetic and immune pathways. TB patient endotype A, comprising 333 TB patients (46.4%), is characterized by increased expression of genes important for i) glycolysis, ii) IL-2-STAT5, IL-6-STAT3, Type I and II Interferon IFN-γ and TNF signaling and iii) epigenetic-modifying genes. In contrast, TB patient endotype B, comprising 313 TB patients (43.6%), is characterized by i) upregulated NFAT and hormone metabolism, and ii) decreased glycolysis, IFN-γ and TNF signaling. In silico evaluation suggests therapies beneficial for endotype A could be detrimental to endotype B, and vice versa. Multiplex ELISA completed from an external validation cohort confirmed a TB patient sub-group with decreased immune upregulation.Conclusions Host immunity to TB is heterogenous. Unbiased clustering analysis identified distinct TB endotypes with divergent metabolic, epigenetic and immune gene expression profiles that may enable stratified or personalized treatment management in the future.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot applicable. Not a clinical trial.Funding StatementNIAID K23 AI141681-02, the Cancer Prevention Institute of Texas (CPRIT) RP170005, NIH P30 shared resource grant CA125123, and NIEHS grants 1P30ES030285 and 1P42ES0327725. CL is funded by the German Center for Infection Research (DZIF). JDC is funded in part from funds provided by the Texas A&M University System and National Institutes of Health grant AI104960. MGN is supported by an ERC Advanced Grant (#833247) and a Spinoza grant of the Netherlands Organization for Scientific Research.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are publicly available as per the manuscript.